Table 3.
Morisky scale | MARS (5-item) | MARS (10-item) | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Unadjusted | Adjusteda | Unadjusted | Adjusted | Unadjusted | Adjusted | |||||||
OR | (95% CI) | OR | (95% CI) | OR | (95% CI) | OR | (95% CI) | OR | (95% CI) | OR | (95% CI) | |
Age | 1 | (0.98–1.01) | 1 | (0.98–1.01) | 0.98 | (0.97–1.00) | 0.98 | (0.96–0.99) | 1 | (0.99–1.02) | 1 | (0.98–1.01) |
Female sex | 0.88 | (0.51–1.50) | 0.86 | (0.48–1.54) | 1.58 | (0.96–2.60) | 1.87 | (1.07–3.27) | 0.72 | (0.41–1.26) | 0.65 | (0.35–1.18) |
Education | ||||||||||||
Basic or secondary | 1 | Refb | 1 | Ref | 1 | Ref | 1 | Ref | 1 | Ref | 1 | Ref |
Professional | 1.43 | (0.82–2.51) | 1.55 | (0.86–2.78) | 1.79 | (1.03–3.11) | 1.91 | (01.05–3.45) | 1.23 | (0.69–2.17) | 1.15 | (0.63–2.08) |
Higher | 1.45 | (0.83–2.53) | 1.72 | (0.92–3.22) | 1.27 | (0.75–2.16) | 1.25 | (0.68–2.29) | 0.97 | (0.56–1.69) | 1.16 | (0.62–2.17) |
Income | ||||||||||||
<300 €/month | 1 | Ref | 1 | Ref | 1 | Ref | 1 | Ref | 1 | Ref | 1 | Ref |
300–550 €/month | 0.83 | (0.45–1.52) | 0.74 | (0.40–1.38) | 0.86 | (0.48–1.55) | 0.89 | (0.48–1.65) | 0.86 | (0.46–1.58) | 0.81 | (0.43–1.53) |
550–750 €/month | 0.67 | (0.33–1.34) | 0.51 | (0.24–1.09) | 0.8 | (0.41–1.59) | 0.66 | (0.31–1.43) | 0.62 | (0.31–1.26) | 0.54 | (0.25–1.17) |
>750 €/month | 1.27 | (0.50–3.22) | 0.92 | (0.33–2.54) | 0.87 | (0.38–2.03) | 0.75 | (0.29–1.93) | 0.77 | (0.32–1.84) | 0.64 | (0.25–1.69) |
Asthma medication | ||||||||||||
Corticosteroids | 1.34 | (0.83–2.16) | 0.82 | (0.49–1.36) | 0.57 | (0.35–0.91) | 0.56 | (0.33–0.93) | 0.69 | (0.42–1.12) | 0.72 | (0.43–1.21) |
Corticosteriods + beta 2 mimetic | 1.04 | (0.64–1.69) | 0.85 | (0.51–1.41) | 1.93 | (1.18–3.16) | 2.04 | (1.19–3.49) | 1.18 | (0.72–1.93) | 1.11 | (0.66–1.86) |
OR odds ratio, CI confidence interval
a Adjusted for age, sex, education and income
b Reference group